E-mail not displaying correctly? View this e-mail online.
North American Quitline Consortium
 FDA Hearing on NRT and Innovative Tobacco Cessation Treatments Scheduled for December 17! 
FDA will hold a public hearing on December 17, 2012, from 8 a.m. to 5 p.m. in Silver Spring, Maryland on the topic of NRT and innovative tobacco cessation treatments.  Anyone who would like to present in-person must register by December 6. A live Web cast of the public hearing will be available and a video recording will also be made available. Highlights of the content of the meeting are provided below and full details are available in the Federal Register Notice

Topics that will be considered at the public hearing include:
  • Fast-track status for smoking cessation products, including NRTs
  • Extended use of NRTs for treatment of tobacco dependence
  • Additional indications for NRTs such as craving relief and relapse prevention
  • Report to Congress on how best to regulate innovative products and treatments  for tobacco cessation, tobacco reduction and reduction in harm from tobacco use
Address of public hearing:
FDA White Oak Campus
10903 New Hampshire Ave
Building 31, Room 1503
Silver Spring, MD 20993
Live Web cast:
https://collaboration.fda.gov/Section918 (recording available at same url)
Submission of comments:
Electronic:  http://www.regulations.gov
Written: Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
For additional information:
Ayanna Augustus
Unsubscribe <<Email Address>> from this list | Forward to a friend | Update your profile
Copyright (C) 2012 North American Quitline Consortium All rights reserved.